Benoît Duculot graduated from ESA Business School in Belgium, and began his career in the hygiene industry in 2004. Over the years, he has held various positions, including Business Developer and Application Specialist, gaining diverse experience in industrial hygiene challenges across multiple sectors.
Today, Benoit holds a position focused on Innovation and Technical Expertise in biofilm control. In this role, he drives the eco-design of environmentally responsible solutions that combine high effectiveness in biofilm prevention, detection, and removal with a reduced environmental footprint. His work aims to deliver robust hygiene performance while optimizing the use of resources, limiting chemical and energy consumption, and contributing to sustainable practices that preserve environmental integrity for future generations.
Throughout his career, he has been involved in numerous industrial cases where microbiological deviations could not be effectively detected or prevented using standard routine methods. To address these challenges, he promoted alternative identification techniques beyond conventional tools and integrated innovative cleaning and disinfection solutions specifically targeting biofilms. His objective is to strengthen process control, enhance microbial risk management, and contribute to more sustainable and resilient hygiene systems.
Since joining GlobalData, Magda has been creating FMCG content on a cross-sector basis including case studies and syndicated projects on product innovations and emerging market trends. Being a part of the Consumer Division, she specializes in packaging, foodservice and consumer goods industries. Magda holds an BSc Honours in Economics and MSc in Economic Policy and Analysis.
Mirko Markovic is Business Development Manager at E.ON Energy Infrastructure Solutions (EIS), where he supports industrial companies in developing future-proof and sustainable energy solutions. With more than a decade of experience across technical sales, engineering and energy infrastructure, Mirko combines technical expertise with a strong understanding of commercial and operational requirements.
At E.ON EIS, he works with international customers to address challenges such as decarbonisation, energy security, rising energy costs and evolving regulatory requirements. His focus is on developing tailored energy solutions that balance technical performance, financial viability and long-term sustainability.
His work encompasses the development of decarbonisation roadmaps, energy infrastructure solutions and flexible partnership models, including Energy-as-a-Service approaches.
As a Business Development Leader, Michael drives Decom Engineering’s global commercial strategy and regional growth across the globe. He leads high-value tendering and multimillion-pound wins, managing a global team to deliver scalable market expansion and board-level strategic insight”
Experience
Accomplished, trilingual MD, PhD clinical oncologist with 18+ years of PHARMA / CRO in different countries.
Deep knowledge in Medical Affairs and Clinical Research and development, specifically clinical trials Phase I
included first in human through Phase IV
> Skilled professional in complex aspect of oncology and molecular genetics, gastrointestinal (gastric cancer, CRC
and HCC), genitourinary cancer, skin cancer and Immunotherapy including CAR-T cell, CAR NK-cell and others)
> Prior to joining PAREXEL, roles included serving as a Senior Oncology / Hematology medical manager in Ely Lilly,
GlaxoSmithKline, ROCHE and as a Latin America Medical Scientific Liaison ASCI (Antigen Specific Cancer
Immunotherapies) for GlaxoSmithKline
> Immediate roles prior to Parexel included 2 years as Oncology / Hematology Associate Medical Director at IQVIA
Expertise
> Expertise in a variety of solid tumors indications (gastrointestinal, genitourinary and skin cancer) and immuno-
oncology and Cell & Gene therapy
> Provide scientific and strategic guidance, training and advice
> Published author in several clinical literature citations in PubMed and other short contributions in oncology books
including update and reviews
Education
> Educate and training as a Clinical Oncologist in Universidad Central de Venezuela (UCV)
PhD in molecular oncology in Instituto Venezolano de Investigaciones Cientificas (IVIC)
Aglinda Hoxha is a senior leader in wealth management, presently a Desk Head HNW at UBS Wealth Management UK. With over two decades of experience across client advisory, front‑office leadership, and risk governance, she is recognised for driving commercial growth while championing a disciplined, client‑centric control environment. Previously serving as Head of Front Office Business Risk Management, Aglinda played a pivotal role in shaping the risk and regulatory framework underpinning the UK franchise, partnering with leadership teams to turn complex requirements into practical enablers of performance. Her foundation in frontline client management—built at Barclays Wealth—continues to guide her coaching‑focused leadership style, which has supported the development of high‑performing professionals across the business. Aglinda holds an Executive MBA from the University of Cambridge and brings a strong perspective on digital innovation, scalable growth, and sustainable client value creation to her role.
